Welcome to LookChem.com Sign In|Join Free

CAS

  • or

231291-13-7

Post Buying Request

231291-13-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

231291-13-7 Usage

Description

3-Fluoro-4-(trifluoromethyl)cinnamic acid, a derivative of cinnamic acid, is a chemical compound characterized by its molecular formula C10H5F4O2. This white crystalline solid is distinguished by the presence of a fluorine atom and a trifluoromethyl group, which endows it with unique chemical properties. It is utilized in organic synthesis and pharmaceutical research, serving as a building block for the creation of various pharmaceuticals and agrochemicals.

Uses

Used in Pharmaceutical Research and Development:
3-Fluoro-4-(trifluoromethyl)cinnamic acid is used as a key intermediate in the synthesis of pharmaceuticals for its unique reactivity and structural properties. Its incorporation into drug molecules can potentially enhance their efficacy and selectivity, making it a valuable component in the development of new therapeutic agents.
Used in Agrochemical Synthesis:
In the agrochemical industry, 3-Fluoro-4-(trifluoromethyl)cinnamic acid is utilized as a building block for the synthesis of various agrochemicals. Its unique chemical properties can contribute to the development of more effective and targeted pesticides and other agricultural chemicals.
Used in Organic Synthesis:
3-Fluoro-4-(trifluoromethyl)cinnamic acid is employed as a versatile reagent in organic synthesis, where its fluorinated and trifluoromethylated structure can be exploited to create a range of organic compounds with diverse applications.
Used in Medical Research:
3-Fluoro-4-(trifluoromethyl)cinnamic acid is studied for its potential anti-inflammatory and antioxidant properties, which makes it of interest for medical research. Its ability to modulate these biological processes could lead to the development of new treatments for various inflammatory and oxidative stress-related conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 231291-13-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,3,1,2,9 and 1 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 231291-13:
(8*2)+(7*3)+(6*1)+(5*2)+(4*9)+(3*1)+(2*1)+(1*3)=97
97 % 10 = 7
So 231291-13-7 is a valid CAS Registry Number.

231291-13-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (E)-3-[3-fluoro-4-(trifluoromethyl)phenyl]prop-2-enoic acid

1.2 Other means of identification

Product number -
Other names JRD-0579

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:231291-13-7 SDS

231291-13-7Relevant articles and documents

17a-HYDROXYLASE/C17,20-LYASE INHIBITORS

-

Paragraph 1090, (2014/03/21)

The present invention provides compounds of Formula (I), or a pharmaceutically acceptable salt thereof, where R1, R2, R3, R4, R5, R6, A and n are as defined herein. A deuteriated derivative of the compound of Formula (I) is also provided.

5,6,7,8-TETRAHYDRO-IMIDAZO[1,5-A]PYRAZINE COMPOUNDS

-

Page/Page column 17, (2011/05/08)

The invention relates to 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives of formula (I) wherein R1, R2, R3, and R4 are as described n the description, to salts, especially pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments; especially as orexin receptor antagonists.

5,6,7,8-TETRAHYDRO-IMIDAZO[1,5-A]PYRAZINE DERIVATIVES

-

Page/Page column 38, (2008/12/06)

The invention relates to 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives of formula (I),wherein X represents CH2 or O; R1 represents a phenyl group, which group is independently mono-, di-, or tri-substituted wherein the substituents are independently selected from the group consisting of (C1-4)alkyl, (C1-4)alkoxy, halogen, cyano, trifluoromethoxy and trifluoromethyl; R2 represents (C1-4)alkyl, (C1-4)alkoxy, (C2-4)alkenyl, halogen, cyano, hydroxymethyl, trifluoromethyl, C(O)NR5R6 or cyclopropyl; R3 represents (C1-4)alkyl, (C1-4)alkoxy-methyl or halogen; R4 represents (C1-4)alkyl; R5 represents hydrogen or (C1-4)alkyl; and R6 represents hydrogen or (C1-4)alkyl. The invention also relates to pharmaceutically acceptable salts of such compounds; and to the use of such compounds as medicaments; especially as orexin receptor antagonists.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 231291-13-7